Current Research Projects
Every study SARRC conducts is valuable to the autism community, but we cannot do it alone. We look to families of individuals impacted by autism to participate in our current research projects. If you're interested in participating in any of our studies, please contact the research team for more information. For a list of current studies and more information, click the study title below:
Early Eye Tracking Study
SARRC is leading an investigational device clinical trial in partnership with Marcus Autism Center, part of Children’s Healthcare of Atlanta. This study will examine the early development of basic social skills in young children. We will observe how children who have autism and other developmental delays and those who are typically developing attend to their social environment. This research could lead to the development of new methods of diagnosing ASD in toddlers.
We are seeking toddlers who are 16 to 30 months old to take part in the study at SARRC. Whether or not your family has concerns about autism or other developmental delays in your child, he or she can participate in our study.
OVID Study (Rocket Study)
This study will evaluate the safety and tolerability of an investigational medication which may help individuals with Fragile X Syndrome. The study is enrolling male participants with Fragile X Syndrome ages 13-22.
This study is currently enrolling children and adolescents to measure the effectiveness and safety of Cannabidiol gel in helping children with their symptoms of Fragile X Syndrome. The study is enrolling children and adolescents with Fragile X Syndrome ages 3 to <18.
ASD Screening Project
SARRC collaborates with more than 100 pediatricians to reduce the age of autism screening and detection. Pediatricians participating in our network screen children for developmental delays at 12-, 18-, and 24-month check-ups, and refer families whose children have scores that indicate a potential developmental delay to SARRC for a developmental evaluation.
» Learn more here. To see if your pediatrician is in our network, contact Stephen at 602.218.8187.
The aim of this study is to investigate the safety and efficacy of a drug designed to help with sociability.
» Learn more here or to register, contact Sharman at 602.218.8225.
ASD and Aging (fMRI Study)
Do you experience subtle social differences? SARRC and Barrow Neurological Institute are investigating the aging process of the brain in individuals with ASD when compared to typically developing peers with the use of fMRI scans.
» To register, contact Anthony Sziklay at 602.218.8199.
ASD and Mindfulness Intervention (fMRI Study)
SARRC and Arizona State University are investigating changes in brain after an 8 week Mindfulness Intervention. Open to all adults 18 and over.
» Learn more here or to register, contact Anthony at 602.218.8199.
This study will evaluate a remote diagnostic procedure, with hopes of improving accessibility to diagnostic evaluations for children ages 18 months to 6 years. En espanol: Dignostico del autismo – obtenga respuestas rapidamente.
To learn more, contact (se habla espanol) Jessica at 602.218.8184.
SPARK is a free study with a simple mission: to speed up research and advance the understanding of autism. An important part of SPARK is the collection of DNA so it can be analyzed to expand our understanding of the role of specific genes in the development of autism. SPARK is hosted by SARRC during various times of year.
To learn more, contact Kendra Coleman at 602.218.8175.
STARS Angelman Snydrome Study
This study will evaluate the safety and effectiveness of an investigational medication on various aspects of Angelman Syndrome, such as motor function, behavior, seizures, and sleep issues. The study is enrolling adults ages 18-49.
To learn more, contact Sharman Ober-Reynolds at 602.218.8225.
Transition Into Adulthood: Skills Study
This study is for adolescents and adults with autism and involves a visit to SARRC’s campus where participants will complete assessments and participate in an interview about transition-related experiences with a member of our clinical team. Responses from these interviews will be used to inform the development of a new intervention for youth with autism.
»Learn more here or to learn more, contact Jessica Laflin at 602.218.8184.